These novel treatments, Retatrutide, represent a significant advancement in managing type 2 diabetes and possibly other disorders. They are grouped as GLP-1 receptor agonists , signifying these substances to mimic the endogenous GLP-1 peptide, boosting insulin production and reducing appetite . Despite Retatrutide each functions relatively simil… Read More